Parexel International News and Activities

Parexel International is a company listed under the stock ticker PRXL (US).

Parexel International has a direct presence in 2 countries.

View the org chart displaying its 37 main executives

Most searched biographies at Parexel International

• Peyton Howell, Chief Executive Officer
• John Groetelaars, Director
• Jeff Bernstein, Director

Popular executive movements at Parexel International

• Boris Braylyan, who was Senior Vice President, Data and Technology, is promoted to Chief Data and Digital Officer  (posted on June 19 2026).

Create your alert
to follow the executive moves at Parexel International.

Parexel International has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Parexel International

Social media about Parexel International

• Parexel International on Wikipedia, Google News & Yahoo Finance
• Parexel International on LinkedIn, X (Twitter) & YouTube